Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $6.5700 (-3.67%) ($6.5700 - $6.5700) on Wed. Oct. 18, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.43% (three month average) | RSI | 49 | Latest Price | $6.5700(-3.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(78%) XBI(77%) IBB(68%) IBUY(67%) ARKK(66%) | Factors Impacting EDIT price | EDIT will decline at least -1.715% in a week (0% probabilities). TBT(-25%) VXX(-22%) VIXM(-17%) UUP(-14%) USO(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.715% (StdDev 3.43%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.09(-147.03%) | Resistance Level | $7.17 | 5 Day Moving Average | $6.9(-4.78%) | 10 Day Moving Average | $7.02(-6.41%) | 20 Day Moving Average | $7.17(-8.37%) | To recent high | -29.2% | To recent low | 0% | Market Cap | $408m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |